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. 1 Tables S2 and S3 respectively. S. olivaceus Tü 3010, Lentzea sp. ATCC 31319, S. thiolactonus NRRL 15439, Streptomyces sp. MG11 and related mutant strains were grown in TSBY or TSB medium 1 for isolation of chromosomal DNA, and on SFM medium 1 for sporulation and conjugation. For production of Tü 3010 in S. olivaceus Tü 3010 the strain was cultured in 2% oatmeal complex medium with a trace element solution, 2 for production of TLM, Lentzea sp. ATCC 31319 was cultured in TSB, and for production of Tü 3010 in S. thiolactonus NRRL 15439
and Streptomyces sp. MG11 strains were cultured in ISP2. 1 For liquid cultures, the strains were grown at 30°C on a rotary shaker incubator at 200 rpm for 4 days, and for solid culture, the strains were grown at 30°C for 5-7 days. All E. coli strains were grown in liquid or solid Luria-Bertani (LB) medium at 37°C with appropriate antibiotic selection (apramycin 50 µg/mL, chloramphenicol 25 µg/mL, kanamycin 50 µg/mL). 3 The ligation mixture was packaged using MaxPlax Lambda Packaging Extracts and plated with E. coli EPI300/pUZ8002. Screening of the S. thiolactonus genomic library for the stu cluster was performed by PCR using primer pairs stuE-up/stuE-dn, stuH-up/stuH-dn, stuA-up/stuA-dn, and stuC-up/stuC-dn.
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Genetic manipulation of thiotetronate-producing strains.
For Lentzea sp. ATCC 31319, in-frame deletions of the tlmA and tlmD1 genes were carried out. The recombinant plasmids pMYtlmA and pMYtlmD1 were constructed by amplifying regions upstream and downstream of tlmA (1.5 kbp on each) and tlmD1 (2 kbp on each) using Lentzea sp. genomic DNA and the primer pairs: tlmA-1F/tlmA-1R, tlmA-2F/tlmA-2R, tlmD1-1F/tlmD1-1R, tlmD1-2F/tlmD1-2R. The vector pYH7 4 was digested with BglII and HindIII, treated with alkaline phosphatase, and purified by gel electrophoresis. Ligation of cut pYH7 and the amplified fragments was accomplished by the isothermal Gibson assembly method according to the manufacturer's protocol. The assembly mixture was incubated at 50°C for 60 min, and then was used to transform E. coli DH10B. Plasmids pMYtlmA and pMYtlmD1 were confirmed by sequencing and were each introduced by conjugation into Lentzea sp. ATCC 31319 through donor strain E. coli ET12567/pUZ8002. After incubation at 30°C for 16 hours, exconjugants were selected with 5 μg/mL apramycin and 25 μg/mL nalidixic acid. Antibiotic resistance was confirmed through transfer of exconjugants to a SFM plate containing 50 μg/mL apramycin and 25 μg/mL nalidixic acid. To form the double cross-over mutants, loss of pMYtlmA and pMYtlmD1 was obtained by several rounds of non-selective growth of the exconconjugants on SFM agar medium. The integrity of the Lentzea sp. tlmA and tlmD1 mutants were checked by PCR analysis using the primer pairs: tlmA-3F/tlmA-3R and tlmD1-3F/tlmD1-3R.
For S. thiolactonus NRRL 15439, gene replacement of stuJ,K,S, and four respective gene in-frame deletions of stuK, stuS, stuH, stuB were carried out.
Taking replacement of stuJ,K,S as an example, the recombinant plasmid pWHU2617 was constructed by amplifying 2 kbp regions upstream and downstream of the stuJ,K,S gene, using S. thiolactonus genomic DNA and the primer pairs: stuJ,K,S-L1/stuJ,K,S-L2 and stuJ,K,S-R1/stuJ,K,S-R2. The pYH7 4 fragment was prepared by digesting with BglII and NdeI, and subsequently treating with alkaline phosphatase. Amplified fragments (2 kbp) after digestion were cloned into BglII and NdeI sites of pYH7 to give an intermediate recombinant. A 827 bp cat resistance gene cassette was amplified using primer pairs: cat-up/cat-dn. Plasmid pWHU2617 was created by inserting the cat cassette between the two 2 kbp amplified fragments.
Restriction digestion and sequencing of inserts were performed to confirm the recombinant plasmid pWHU2617, which was then introduced into S. thiolactonus NRRL 15439 by conjugation. Screening for gene replacement mutant of stuJ,K,S was performed as described for tlmA mutant screening.
Recombinant strain S. thiolactonus stuJ,K,S::cat was confirmed by PCR using primer pairs: stuJ,K,S-CK1/stuJ,K,S-CK2 and Southern blot analysis.
The in-frame deletion of each of stuK, stuS, stuH, stuB were carried out similarly. Recombinant plasmids, pWHU2639, pWHU2640, pWHU2674 and pWHU2673 were constructed by amplifying 2 kbp regions upstream and downstream of the target gene, using the primer pairs: stuK-L1/stuK-L2 and stuK-R1/stuK-R2 (stuK), stuS-L1/stuS-L2 and stuS-R1/stuS-R2 (stuS), stuH-L1/stuH-L2 and stuH-R1/stuH-R2 (stuH), stuB-L1/stuB-L2 and stuB-R1/stuB-R2 (stuB), respectively. The resulting recombinant plasmids were each introduced into S. thiolactonus and screened for the in-frame deletion mutants of interest, as described previously. All mutants were validated by PCR analysis, using the check primers listed in Table S4 .
Trans-complementation was carried out by introducing the complementation plasmids pIB-tlmA, pWHU2698, pWHU2699, pWHU2700 and pWHU2701 into the corresponding gene-null mutant. The integrative vector pIB139 was used for inserting tlmA, stuJ, stuK, stuS, stuJ+S under the control of the ermE* promoter, respectively. Genes including tlmA (2 kbp), stuJ (1 kbp), stuK (666 bp) and stuS (1 kbp), were amplified using primer pairs:
tlmA-NdeI/tlmA-XbaI, stuJ-up/stuJ-dn, stuK-up/stuK-dn, stuS-up/stuS-dn, respectively. The resulting products were digested with NdeI and XbaI, and then cloned into the corresponding site of pIB139, except for stuS which was digested with NdeI and EcoRI and inserted into the NdeI and EcoRI site of pIB139. After sequencing confirmation, each plasmid was introduced into the appropriate gene-null mutant and analyzed for the production of thiotetronate antibiotic. 
